![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | ISO | RGD:1322370 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of GPR157 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1322370 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPR157 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPR157 mRNA | CTD | PMID:32109520, PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1322371 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPR157 mRNA | CTD | PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1322371 | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GPR157 mRNA | CTD | PMID:25975270 | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:1322371 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of GPR157 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of GPR157 mRNA | CTD | PMID:36041667 | afimoxifene | multiple interactions | ISO | RGD:1322370 | 6480464 | afimoxifene inhibits the reaction [Estrogens results in decreased expression of GPR157 mRNA] | CTD | PMID:21233418 | aflatoxin B1 | increases methylation | ISO | RGD:1322370 | 6480464 | Aflatoxin B1 results in increased methylation of GPR157 polyA tail | CTD | PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | RGD:1322370 | 6480464 | aflatoxin B2 results in increased methylation of GPR157 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | RGD:1322370 | 6480464 | Tretinoin results in decreased expression of GPR157 mRNA | CTD | PMID:33167477 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of GPR157 gene | CTD | PMID:28931070 | benzo[a]pyrene | affects methylation | ISO | RGD:1322370 | 6480464 | Benzo(a)pyrene affects the methylation of GPR157 promoter | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | RGD:1322370 | 6480464 | benzo(e)pyrene results in increased methylation of GPR157 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GPR157 mRNA | CTD | PMID:25181051 more ... | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of GPR157 mRNA | CTD | PMID:36041667 | bisphenol A | increases expression | ISO | RGD:1322371 | 6480464 | bisphenol A results in increased expression of GPR157 mRNA | CTD | PMID:34585602 | bisphenol A | decreases methylation | ISO | RGD:1322371 | 6480464 | bisphenol A results in decreased methylation of GPR157 promoter | CTD | PMID:27312807 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of GPR157 mRNA | CTD | PMID:36041667 | bortezomib | decreases expression | ISO | RGD:1322370 | 6480464 | Bortezomib results in decreased expression of GPR157 mRNA | CTD | PMID:20977926 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of GPR157 mRNA | CTD | PMID:19167457 | carbon nanotube | decreases expression | ISO | RGD:1322371 | 6480464 | Nanotubes, Carbon analog results in decreased expression of GPR157 mRNA | CTD | PMID:25554681 | cisplatin | decreases expression | ISO | RGD:1322370 | 6480464 | Cisplatin results in decreased expression of GPR157 mRNA | CTD | PMID:27392435 | cocaine | decreases expression | EXP | | 6480464 | Cocaine results in decreased expression of GPR157 mRNA | CTD | PMID:27899881 | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of GPR157 mRNA | CTD | PMID:26033743 | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of GPR157 mRNA | CTD | PMID:26033743 | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of GPR157 mRNA | CTD | PMID:27523638 | dimethylarsinic acid | multiple interactions | ISO | RGD:1322371 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR157 mRNA | CTD | PMID:34876320 | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GPR157 mRNA | CTD | PMID:33729688 | doxorubicin | decreases expression | ISO | RGD:1322370 | 6480464 | Doxorubicin results in decreased expression of GPR157 mRNA | CTD | PMID:29803840 | entinostat | increases expression | ISO | RGD:1322370 | 6480464 | entinostat results in increased expression of GPR157 mRNA | CTD | PMID:27188386 | folic acid | decreases expression | ISO | RGD:1322371 | 6480464 | Folic Acid results in decreased expression of GPR157 mRNA | CTD | PMID:25629700 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of GPR157 mRNA | CTD | PMID:33387578 | lipopolysaccharide | decreases expression | ISO | RGD:1322371 | 6480464 | Lipopolysaccharides results in decreased expression of GPR157 mRNA | CTD | PMID:25890327 | lipopolysaccharide | increases expression | ISO | RGD:1322370 | 6480464 | Lipopolysaccharides results in increased expression of GPR157 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | RGD:1322370 | 6480464 | S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GPR157 mRNA] | CTD | PMID:35811015 | methapyrilene | increases methylation | ISO | RGD:1322370 | 6480464 | Methapyrilene results in increased methylation of GPR157 intron | CTD | PMID:30157460 | methylarsonic acid | multiple interactions | ISO | RGD:1322371 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR157 mRNA | CTD | PMID:34876320 | paracetamol | increases expression | ISO | RGD:1322370 | 6480464 | Acetaminophen results in increased expression of GPR157 mRNA | CTD | PMID:22230336, PMID:29067470 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GPR157 mRNA | CTD | PMID:33387578 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of GPR157 mRNA | CTD | PMID:32680482 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RGD:1322370 | 6480464 | S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GPR157 mRNA] | CTD | PMID:35811015 | sodium arsenate | multiple interactions | ISO | RGD:1322371 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR157 mRNA | CTD | PMID:34876320 | sodium arsenite | multiple interactions | ISO | RGD:1322371 | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR157 mRNA | CTD | PMID:34876320 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of GPR157 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | RGD:1322371 | 6480464 | titanium dioxide results in increased expression of GPR157 mRNA | CTD | PMID:29264374 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of GPR157 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | RGD:1322370 | 6480464 | trichostatin A results in increased expression of GPR157 mRNA | CTD | PMID:24935251 | triclosan | decreases expression | ISO | RGD:1322370 | 6480464 | Triclosan results in decreased expression of GPR157 mRNA | CTD | PMID:30510588 | valproic acid | affects expression | ISO | RGD:1322371 | 6480464 | Valproic Acid affects the expression of GPR157 mRNA | CTD | PMID:17963808 | valproic acid | increases methylation | ISO | RGD:1322370 | 6480464 | Valproic Acid results in increased methylation of GPR157 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | RGD:1322370 | 6480464 | Valproic Acid results in increased expression of GPR157 mRNA | CTD | PMID:23179753 more ... | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of GPR157 mRNA | CTD | PMID:23034163 | vorinostat | increases expression | ISO | RGD:1322370 | 6480464 | vorinostat results in increased expression of GPR157 mRNA | CTD | PMID:27188386 | |